http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5900607

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 1192
issn 0269-2813
issueIdentifier 10
pageRange 1185-1192
publicationName Alimentary Pharmacology & Therapeutics
startingPage 1185
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bd535aa2864ee0e4fbecb46ec7d40fa7
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_92bc7d6e80f4a836d828a83cec929654
bibliographicCitation Imam MH, Sinakos E, Gossard AA, Kowdley KV, Luketic VA, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, DeCook AC, Enders F, Lindor KD. High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Aliment Pharmacol Ther. 2011 Nov;34(10):1185–92. PMID: 21957881; PMCID: PMC3752281.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afb3b615ef63b5b6ef0f1da91f70de55
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac33926268a975e86624c3ea99218ccd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c76a7ef65f37f2485d11a617c3bdd944
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39811fdc068bfc57f29c236ea08d60e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33d89c97db7e8e84ee256a104ae9eb84
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d44a0651266781d9b5036a9edeb47bb1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a11b5f3c50ea0f1d50fab2cbdcf555e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2bd92f590bd2150cc49d5374dc272bc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1952f45fbbeaa54ffd27d31e9b208dbf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ece1214b6a0b6023267ba8913cf614c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6e37fdeed575fc3acc000e9e455f3d1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07489c5aac12e3ee094ef8ef691ff789
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d544a22a7697ac0c0fdc0f1c6dd8aec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0d131198b73f5511e669d7bf95b0d53
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a572d406b6ec54608ada5c2794c5871
date 2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3752281
https://doi.org/10.1111/j.1365-2036.2011.04863.x
https://pubmed.ncbi.nlm.nih.gov/21957881
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1160
https://portal.issn.org/resource/ISSN/0269-2813
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
discusses http://id.nlm.nih.gov/mesh/M0002494
http://id.nlm.nih.gov/mesh/M0022413
http://id.nlm.nih.gov/mesh/M0004221
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015209Q000188
http://id.nlm.nih.gov/mesh/D002756Q000009
http://id.nlm.nih.gov/mesh/D014580Q000009
http://id.nlm.nih.gov/mesh/D001663Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D002756Q000008
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D053208
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D015209Q000097
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D014580Q000008
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D013997
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9676
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.3.1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7646
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10192
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31401
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129182106

Total number of triples: 65.